LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10852 | 10512 | 1.0323 | 1.0185 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10758 | 10692 | 1.0062 | 1.0035 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10068 | 10512 | 0.9577 | 0.9750 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 962 | 9601 | 10692 | 0.8980 | 0.9390 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 962 | 5546 | 10512 | 0.5281 | 0.6616 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 962 | 7429 | 10692 | 0.6949 | 0.8008 |
MCF 10A | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 962 | 1428 | 10512 | 0.1361 | 0.1209 |
MCF 10A | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 962 | 1760 | 10692 | 0.1647 | 0.1896 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 962 | 806 | 10512 | 0.0768 | -0.0511 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 962 | 745 | 10692 | 0.0697 | -0.0725 |
MCF 10A | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 962 | 480 | 10512 | 0.0457 | -0.1828 |
MCF 10A | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 962 | 491 | 10692 | 0.0460 | -0.1764 |
MCF 10A | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10548 | 10512 | 1.0036 | 1.0021 |
MCF 10A | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 962 | 10506 | 10512 | 0.9998 | 0.9998 |
MCF 10A | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 962 | 10111 | 10512 | 0.9622 | 0.9778 |
MCF 10A | Brivanib | 1.11 | uM | LJP5 | 72 | hr | 962 | 9258 | 10512 | 0.8810 | 0.9279 |
MCF 10A | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 962 | 7242 | 10512 | 0.6892 | 0.7953 |
MCF 10A | Brivanib | 10 | uM | LJP5 | 72 | hr | 962 | 2440 | 10512 | 0.2323 | 0.3095 |
MCF 10A | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 962 | 11451 | 10692 | 1.0711 | 1.0399 |
MCF 10A | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 962 | 11249 | 10692 | 1.0522 | 1.0294 |
MCF 10A | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 962 | 11501 | 10692 | 1.0758 | 1.0424 |
MCF 10A | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 962 | 11066 | 10692 | 1.0351 | 1.0198 |
MCF 10A | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 962 | 10194 | 10692 | 0.9534 | 0.9727 |
MCF 10A | CHIR-99021 | 10 | uM | LJP6 | 72 | hr | 962 | 8827 | 10692 | 0.8254 | 0.8918 |
MCF 10A | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 962 | 11413 | 10692 | 1.0675 | 1.0380 |